Back to Authors

Qiang, Li

0000-0002-2354-177X

Mayo Clinic

Biochemistry and Molecular Biology Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN.

Citations 2

Dynamin 2 interacts with α-actinin 4 to drive tumor cell invasion

Molecular Biology of the Cell | May 18, 2020 | Volume: 31 | Issue: 6 | Pages: 439-451

10.1091/mbc.e19-07-0395 | PMID 31967944

Dyn2 and α-actinin 4 interact directly to regulate invasive cell migration and the stabilization of invadopodia. Intriguingly, this is specific for α-actinin 4, and not the highly related protein α-actinin 1. These findings elucidate a novel mechanism of regulating cell migration, with important implications for invasive tumor cells.
Pancreatic tumor cell metastasis is restricted by MT1-MMP binding protein MTCBP-1

Journal of Cell Biology | November 28, 2018 | Volume: 218 | Issue: 1 | Pages: 317-332

10.1083/jcb.201802032 | PMID 30487181

The process by which tumor cells mechanically invade through surrounding stroma into peripheral tissues is an essential component of metastatic dissemination. The directed recruitment of the metalloproteinase MT1-MMP to invadopodia plays a critical role in this invasive process. Here, we provide mechanistic insight into MT1-MMP cytoplasmic tail binding protein 1 (MTCBP-1) with respect to invadopodia formation, matrix remodeling, and invasion by pancreatic tumor cells. MTCBP-1 localizes to invadopodia and interacts with MT1-MMP. We find that this interaction displaces MT1-MMP from invadopodia, thereby attenuating their number and function and reducing the capacity of tumor cells to degrade matrix. Further, we observe an inverse correlation between MTCBP-1 and MT1-MMP expression both in cultured cell lines and human pancreatic tumors. Consistently, MTCBP-1–expressing cells show decreased ability to invade in vitro and metastasize in vivo. These findings implicate MTCBP-1 as an inhibitor of the metastatic process.